EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improving mitotic cell counting accuracy and efficiency using phosphohistone‐H3 ( PHH3 ) antibody counterstained with haematoxylin and eosin as part of breast cancer grading

Asmaa Ibrahim iD, Michael S Toss iD, Shorouk Makhlouf iD, Islam M Miligy iD, Fayyaz Minhas iD, Emad A Rakha iD

Histopathology · 2023-02 · 82 (3) · 393-406

DOI: 10.1111/his.14837 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, online erschienen am 18.11.2022. Verfasst von Asmaa Ibrahim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, U…. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Egyptian Cultural and Educational Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mitotic count in breast cancer is an important prognostic marker. Unfortunately, substantial inter‐ and intraobserver variation exists when pathologists manually count mitotic figures. To alleviate this problem, we developed a new technique incorporating both haematoxylin and eosin (H&E) and phosphorylated histone H3 (PHH3), a marker highly specific to mitotic figures, and compared it to visual scoring of mitotic figures using H&E only.

Methods

Two full‐face sections from 97 cases were cut, one stained with H&E only, and the other was stained with PHH3 and counterstained with H&E (PHH3–H&E). Counting mitoses using PHH3–H&E was compared to traditional mitoses scoring using H&E in terms of reproducibility, scoring time, and the ability to detect mitosis hotspots. We assessed the agreement between manual and image analysis‐assisted scoring of mitotic figures using H&E and PHH3–H&E‐stained cells. The diagnostic performance of PHH3 in detecting mitotic figures in terms of sensitivity and specificity was measured. Finally, PHH3 replaced the mitosis score in a multivariate analysis to assess its significance.

Results

Pathologists detected significantly higher mitotic figures using the PHH3–H&E (median ± SD, 20 ± 33) compared with H&E alone (median ± SD, 16 ± 25), P < 0.001. The concordance between pathologists in identifying mitotic figures was highest when using the dual PHH3–H&E technique; in addition, it highlighted mitotic figures at low power, allowing better agreement on choosing the hotspot area ( k = 0.842) in comparison with standard H&E ( k = 0.625). A better agreement between image analysis‐assisted software and the human eye was observed for PHH3‐stained mitotic figures. When the mitosis score was replaced with PHH3 in a Cox regression model with other grade components, PHH3 was an independent predictor of survival (hazard ratio [HR] 5.66, 95% confidence interval [CI] 1.92–16.69; P = 0.002), and even showed a more significant association with breast cancer‐specific survival (BCSS) than mitosis (HR 3.63, 95% CI 1.49–8.86; P = 0.005) and Ki67 ( P = 0.27).

Conclusion

Using PHH3–H&E‐stained slides can reliably be used in routine scoring of mitotic figures and integrating both techniques will compensate for each other's limitations and improve diagnostic accuracy, quality, and precision.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleEosine Yellowish-(YS)Mitotic IndexHematoxylinReproducibility of ResultsBiomarkers, TumorImmunohistochemistryMitosisAntibodiesPhosphorylation

Stichwörter der Autor:innen

Breast cancerWSIcountmitosis

Substanzen

Eosine Yellowish-(YS)HematoxylinBiomarkers, TumorAntibodies

Autor:innen und Institutionen

  • Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK.
  • Histopathology department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
  • Department of Pathology, Faculty of Medicine, Assiut University, Assiut, Egypt.
  • Histopathology department, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt.
  • Histopathology department, School of Medicine, University of Nottingham, Nottingham, UK.
  • Department of Computer Science, University of Warwick, Coventry, UK.

ORCID-Profile: Asmaa Ibrahim, Michael S Toss, Shorouk Makhlouf, Islam M Miligy, Fayyaz Minhas, Emad A Rakha

Förderung

  • Egyptian Cultural and Educational Bureau

Zitieren

APA

Ibrahim, A., Toss, M. S., Makhlouf, S., Miligy, I. M., Minhas, F., & Rakha, E. A. (2023). Improving mitotic cell counting accuracy and efficiency using phosphohistone‐H3 ( PHH3 ) antibody counterstained with haematoxylin and eosin as part of breast cancer grading. Histopathology, 82(3), 393-406. https://doi.org/10.1111/his.14837

Vancouver

Ibrahim A, Toss MS, Makhlouf S, Miligy IM, Minhas F, Rakha EA. Improving mitotic cell counting accuracy and efficiency using phosphohistone‐H3 ( PHH3 ) antibody counterstained with haematoxylin and eosin as part of breast cancer grading. Histopathology. 2023;82(3):393-406. doi:10.1111/his.14837

BibTeX
@article{Ibrahim2023,
  author = {Ibrahim, Asmaa and Toss, Michael S and Makhlouf, Shorouk and Miligy, Islam M and Minhas, Fayyaz and Rakha, Emad A},
  title = {Improving mitotic cell counting accuracy and efficiency using phosphohistone‐H3 ( PHH3 ) antibody counterstained with haematoxylin and eosin as part of breast cancer grading},
  journal = {Histopathology},
  year = {2023},
  volume = {82},
  number = {3},
  pages = {393--406},
  doi = {10.1111/his.14837}
}
Kostenlos starten →